Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Review

Using Artificial Intelligence to Identify Patterns and Predictors of Adverse Drug Reactions in Cardiovascular Patients: A Comprehensive Narrative Review

Erfan Shahabinejad Fatemeh Soflaei-Shahrbabak Marzieh Gholami Shoa Aida Azhdarimoghaddam M. Mozafar Pouya Yektaee-Rad Samar Monajemi Shayan Ghanouni Shuhao Qiu Mani Khorsand Askari
Jul 2026 · American Journal of Cardiovascular Drugs · Vol 26, pp. 537 - 557 · 0 citations · 137 references
Medicine

TL;DR

This narrative review synthesizes current evidence on AI applications across the cardiovascular PV continuum, including safety signal detection, patient-level risk prediction, and text-based surveillance and holds substantial promise for enhancing cardiovascular drug safety.

DOI PubMed Semantic Scholar
View source

Similar papers

Review Aug 2026

Advancing Pharmacovigilance: AI and Deep Learning Approaches to Detect Adverse Drug Reactions from Big Data

The systematic monitoring of post-marketing drug safety is paramount to ensuring patient welfare and population-level health, requiring the timely detection and prevention of adverse drug events. Traditional pharmacovigilance schemes, which largely rely on spontaneous reporting, have weaknesses, including underrepo...

C. R. Darwin, Meruva Sathish Kumar, S. Marakatham et al. · 0 citations
Review Open access Aug 2026

Review Article: Adverse Drug Reaction (ADR) Signal Detection

Adverse drug reaction (ADR) signal detection is the process of identifying new or previously unclear associations between a medicine and an unwanted effect, using data collected after the medicine has been approved for use. Because clinical trials involve limited numbers of patients over a short period, many uncommon o...

Mohamed Arshak, Mohamed Shafeek A, A. A · 0 citations
Review Open access Sep 2026

Leveraging Claude AI for Advanced ADR Detection and Pharmacovigilance: Innovations in Pharmacy Practice

Background: Adverse drug reactions (ADRs) continue to be a leading source of morbidity, hospitalization, hospital stay, and avoidable health expenditure. The conventional pharmacovigilance process has relied heavily upon spontaneous, manual reporting, prone to the following limitations: under-reporting, delayed reporti...

Chethana Mv · 0 citations
Review Open access Sep 2026

Artificial intelligence–driven risk prediction of polypharmacy in older adults: current advances, clinical applications, and future perspectives

Due to the ageing of the population, multimorbidity and polypharmacy has significantly increased, causing medication safety to become a global health concern. Traditionally, medication risk assessment methods based on the counts of medications or rule-based criteria are inadequate to perceive the dynamic, individual an...

Jian-Feng Chen, Le-Yu Tao · 0 citations
#large language models Review Open access Sep 2026

A Review On: Artificial Intelligence in Preclinical and Clinical Trials

Challenges such as data quality, algorithmic bias, lack of transparency, privacy, cybersecurity, regulatory uncertainty and the need for human oversight remain important.

Rajashree Somnath Chorgade, Srushti Dipak Nevase, Shubham Hanumant Dhavale et al. · 0 citations
Open access Sep 2026

Revolutionising Clinical Trials with Artificial Intelligence: A Paradigm Shift in Drug Development

AI is revolutionising clinical trials by improving efficiency, accuracy, and decision-making throughout the study process. Traditional clinical trials are frequently time-consuming, expensive, and constrained by factors such as patient recruiting delays, protocol complexity, data management concerns, and high dropout r...

E. Nikitha, K. L. Supriya, K. Rakesh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.